NM_000202.8:c.389C>T
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PM1PM2PM5PP3_StrongPP5_Very_Strong
The NM_000202.8(IDS):c.389C>T(p.Thr130Ile) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. T130A) has been classified as Uncertain significance.
Frequency
Consequence
NM_000202.8 missense
Scores
Clinical Significance
Conservation
Publications
- mucopolysaccharidosis type 2Inheritance: XL, AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), ClinGen, Genomics England PanelApp, PanelApp Australia, Myriad Women’s Health
- mucopolysaccharidosis type 2, attenuated formInheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
- mucopolysaccharidosis type 2, severe formInheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_000202.8. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| IDS | NM_000202.8 | MANE Select | c.389C>T | p.Thr130Ile | missense | Exon 3 of 9 | NP_000193.1 | ||
| IDS | NM_001166550.4 | c.119C>T | p.Thr40Ile | missense | Exon 3 of 9 | NP_001160022.1 | |||
| IDS | NM_006123.5 | c.389C>T | p.Thr130Ile | missense | Exon 3 of 8 | NP_006114.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| IDS | ENST00000340855.11 | TSL:1 MANE Select | c.389C>T | p.Thr130Ile | missense | Exon 3 of 9 | ENSP00000339801.6 | ||
| IDS | ENST00000370441.8 | TSL:1 | c.389C>T | p.Thr130Ile | missense | Exon 3 of 8 | ENSP00000359470.4 | ||
| IDS | ENST00000466323.5 | TSL:1 | n.389C>T | non_coding_transcript_exon | Exon 3 of 9 | ENSP00000418264.1 |
Frequencies
GnomAD3 genomes Cov.: 23
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 23
ClinVar
Submissions by phenotype
Mucopolysaccharidosis, MPS-II Pathogenic:2
Absent from controls (or at low frequency) in gnomAD database (PM2_Moderate), Missense change at the same amino acid residue as a pathogenic variant (PM5_Moderate), Missense variant in a gene with a low rate of benign missense variation (PP2_Supporting), Multiple lines of computational evidence support a deleterious effect (PP3_Supporting), Patient’s phenotype or family history highly specific for the disease (PP4_Moderate)
This sequence change replaces threonine, which is neutral and polar, with isoleucine, which is neutral and non-polar, at codon 130 of the IDS protein (p.Thr130Ile). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individuals with mucopolysaccharidosis type II (PMID: 21829674, 24125893; Invitae). ClinVar contains an entry for this variant (Variation ID: 527323). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt IDS protein function with a positive predictive value of 80%. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at